These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 14737948)

  • 1. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients.
    Kozłowski L; Zakrzewska I; Tokajuk P; Wojtukiewicz MZ
    Rocz Akad Med Bialymst; 2003; 48():82-4. PubMed ID: 14737948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival.
    Benoy IH; Salgado R; Van Dam P; Geboers K; Van Marck E; Scharpé S; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2004 Nov; 10(21):7157-62. PubMed ID: 15534087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of plasma interleukin-6 and interleukin-8 in monitoring of patients with breast cancer].
    Zakrzewska I; Omyła J
    Pol Merkur Lekarski; 2005 Apr; 18(106):424-6. PubMed ID: 16161926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
    Zhang GJ; Adachi I
    Anticancer Res; 1999; 19(2B):1427-32. PubMed ID: 10365118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in serum IL-6 after vacination of breast cancer patients with tumour-associated antigens is related to estrogen receptor status.
    Jiang XP; Yang DC; Elliott RL; Head JF
    Cytokine; 2000 May; 12(5):458-65. PubMed ID: 10857759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The levels of selected cytokines in patients with colorectal cancer--a preliminary report].
    Grotowski M; Piechota W
    Pol Merkur Lekarski; 2001 Oct; 11(64):327-9. PubMed ID: 11770312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between IL-10 and tumor markers in breast cancer patients.
    Llanes-Fernández L; Alvarez-Goyanes RI; Arango-Prado Mdel C; Alcocer-González JM; Mojarrieta JC; Pérez XE; López MO; Odio SF; Camacho-Rodríguez R; Guerra-Yi ME; Madrid-Marina V; Tamez-Guerra R; Rodríguez-Padilla C
    Breast; 2006 Aug; 15(4):482-9. PubMed ID: 16403632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Secreto G; Romelli B; Fumagalli G; Rovelli F; Colciago M; Brera G
    In Vivo; 2007; 21(4):647-50. PubMed ID: 17708360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum evaluation of interleukin 6 in ovarian cancer patients.
    Tempfer C; Zeisler H; Sliutz G; Haeusler G; Hanzal E; Kainz C
    Gynecol Oncol; 1997 Jul; 66(1):27-30. PubMed ID: 9234916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma.
    Snoussi K; Strosberg AD; Bouaouina N; Ben Ahmed S; Chouchane L
    Eur Cytokine Netw; 2005 Dec; 16(4):253-60. PubMed ID: 16464738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
    Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of serum IL-6, IL-8 and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma.
    Nacinović-Duletić A; Stifter S; Dvornik S; Skunca Z; Jonjić N
    Int J Lab Hematol; 2008 Jun; 30(3):230-9. PubMed ID: 18479302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy.
    Bozcuk H; Uslu G; Samur M; Yildiz M; Ozben T; Ozdoğan M; Artaç M; Altunbaş H; Akan I; Savaş B
    Cytokine; 2004 Jul 21-Aug 7; 27(2-3):58-65. PubMed ID: 15242694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of cytokines and thyroid function in patients with recurrent breast cancer.
    Yokoe T; Iino Y; Takei H; Horiguchi J; Koibuchi Y; Maemura M; Ohwada S; Morishita Y
    Anticancer Res; 1997; 17(1B):695-9. PubMed ID: 9066604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions.
    Coskun U; Bukan N; Sancak B; Günel N; Ozenirler S; Unal A; Yucel A
    Neoplasma; 2004; 51(3):209-13. PubMed ID: 15254675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis.
    Ebrahimi B; Tucker SL; Li D; Abbruzzese JL; Kurzrock R
    Cancer; 2004 Dec; 101(12):2727-36. PubMed ID: 15526319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of IL-10 in the serum of patients with advanced ovarian cancer: results from a prospective pilot-study.
    Mustea A; Braicu EI; Koensgen D; Yuan S; Sun PM; Stamatian F; Lichtenegger W; Chen FC; Chekerov R; Sehouli J
    Cytokine; 2009 Jan; 45(1):8-11. PubMed ID: 19071030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of interleukin-8 determination in diagnosis of benign and malignant breast tumor].
    Zakrzewska I; Kozłowski L; Wojtukiewicz M
    Pol Merkur Lekarski; 2002 Oct; 13(76):302-4. PubMed ID: 12557436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of inflammatory cytokines in the progression of colorectal cancer.
    Chung YC; Chang YF
    Hepatogastroenterology; 2003; 50(54):1910-3. PubMed ID: 14696431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interleukin-6 and its soluble receptors in human breast cancer].
    Kuang Y; Zhang Z; Zhang X
    Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):305-7. PubMed ID: 10920992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.